We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Mycoplasma genitalium in Symptomatic Male Urethritis: Macrolide Use Is Associated With Increased Resistance.
- Authors
Li, Yang; Su, Xiaohong; Le, Wenjing; Li, Sai; Yang, Zhaoyan; Chaisson, Christine; Madico, Guillermo; Gong, Xiangdong; Reed, George W; Wang, Baoxi; Rice, Peter A
- Abstract
Background Mycoplasma genitalium (MG) causes symptomatic urethritis in men, and can infect alone or together with other sexually transmitted infection (STI) agents. Methods The prevalence of MG and other STIs was determined in 1816 men with symptomatic urethritis. Resistance of MG to macrolides and fluoroquinolones was determined by sequencing; the impact of recent antimicrobial usage on the distribution of MG single or mixed infections was determined. Results Overall, prevalence of MG infection was 19.7% (358/1816). Fifty-four percent (166/307) of MG infections occurred alone in the absence of other STI agents. Men with single MG infection self-administered or were prescribed antibiotics more often in the 30 days prior to enrollment than subjects with urethritis caused by MG coinfection (P <.0001). Higher rates (96.7%) of infection with macrolide resistance in MG were identified in men who had taken macrolides prior to enrollment (P <.03). Overall, 88.9% (303/341) of 23S ribosomal RNA (rRNA) genes contained mutations responsible for macrolide resistance; 89.5% (308/344) of parC and 12.4% (42/339) of gyrA genes had mutations responsible for fluoroquinolone resistance. Approximately 88% (270/308) of MG had combined mutations in 23S rRNA and parC genes; 10.4% (32/308) had mutations in all 3 genes. Conclusions MG was the single pathogen identified in 11% of men with symptomatic urethritis. Overall, nearly 90% of MG infections were resistant to macrolides and fluoroquinolones. Men who took macrolides in the 30 days prior to enrollment had higher rates (97%) of macrolide-resistant MG. Resistance was associated with numerous mutations in 23SrRNA, parC , and gy r A genes.
- Subjects
EPIDEMIOLOGY of sexually transmitted diseases; ANTI-infective agents; BACTERIAL diseases; DRUG resistance in microorganisms; GENES; MACROLIDE antibiotics; GENETIC mutation; MYCOPLASMA; MYCOPLASMA diseases; URETHRITIS; DISEASE prevalence; FLUOROQUINOLONES; DESCRIPTIVE statistics; SEQUENCE analysis; MIXED infections
- Publication
Clinical Infectious Diseases, 2020, Vol 70, Issue 5, p805
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciz294